Peptide profiler
Quick adme quote
Connect with us
Connect your science
Connect your science

We connect you with specific subject matter experts to ensure support and recommendations tailored to your project.

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
We will respond to you within 24 hours of your enquiry being received.
‍
You can also find Concept Life Sciences on the following platforms:

12/3/2025

to

14/3/2025

London

NextGen Biomed 2025

Showcasing the latest advancements in the discovery & development of novel immunotherapies and biologics.

VISIT EVENT WEBSITE

The we are presenting in the immunotherapy & immuno-oncology program at the NextGen BioMed conference happening this spring. This event provides a platform for sharing research and learning about the latest advancements in discovering and developing novel immunotherapies and biologics.

Upcoming Events Schedule
Search
Clear
Country
Clear
Select
Month
Clear
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
Event
Eurotox
Vienna
,
Sep 13, 2026
September
Event
CHI Discovery on Target
Sheraton Boston
,
United States
Sep 28, 2026
September
Event
CPHI Milan 2026
Fiera Milano
,
Italy
Oct 6, 2026
October
Event
BioJapan
Pacifico Yokohama
,
Oct 7, 2026
October
No results found.
There are no results with this criteria. Try changing your search.
News and Expert Knowledge
Search
Clear
Type
Clear
Select
Relevant Service Line
Clear
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
Expert Knowledge
Why a tailored ADME strategy is essential to unlock the potential of peptide therapeutics

by:
Barbara Marsiglia - Principal Scientist
Service Line:
Therapeutic Modalities
News
New Biosciences Appointments Strengthen Capability at Concept Life Sciences

We are pleased to announce the appointment of two new senior hires to strengthen our expertise and offering across Biosciences, reinforcing our position as a trusted partner in drug discovery and development.

by:
Service Line:
Biology
Expert Knowledge
Selecting the Ideal CDMO for Clinical Success

Why choose Concept Life Sciences as your CDMO of choice?

by:
Jamie Stokes
Service Line:
Chemistry
News
Concept Life Sciences partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech

Partnership to provide faster, lower-risk paths to high-quality chemical starting points

by:
Service Line:
Integrated Drug Discovery
Expert Knowledge
Meet the Team: The Scientists Powering Expanded Assay Development and Screening Capability

Concept Life Sciences’ expanded assay and screening capabilities strengthen its integrated approach to accelerating drug discovery. But beyond the technology, we spoke with the team about their perspectives, challenges, and motivations.

by:
Service Line:
Integrated Drug Discovery
Expert Knowledge
Concept Life Sciences awarded Platinum Sustainability Award from My Green Lab

Our Sustainability team had a mission to find small changes that could make a big difference to our chemistry labs' sustainability: we've now been awarded Platinum status from My Green Lab

by:
Service Line:
Expert Knowledge
The Future of Safer, More Predictive Drug Development

Insights on New Approach Methodologies (NAMs)

by:
Service Line:
Biology
News
Concept Life Sciences Wins SCI-RSC National Retrosynthesis Competition

by:
Service Line:
Chemistry
Expert Knowledge
Why APIs Fail At Scale: It’s Not The Molecule, It’s The Route

A critical step in de-risking your API – Paving the way from lab to commercial scale

by:
David Fengas
Service Line:
Chemistry
Expert Knowledge
Can’t "Fix It Later" - How Early Integration Prevents Development Failure

This article highlights why early integration is essential to avoid costly delays and development failure. By aligning scientific, technical, and regulatory inputs from the start, organisations can de-risk programmes and accelerate progress.

by:
David Fengas
Service Line:
Chemistry
No results found.
There are no results with this criteria. Try changing your search.